Lancet. 2016 Mar 5;387(10022):1012-1024. doi: 10.1016/S0140-6736(15)00055-0. Epub 2015 Aug 28.
PMID:26321262
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.
Tang LL, Chen YP, Chen CB, Chen MY, Chen NY, Chen XZ, Du XJ, Fang WF, Feng M, Gao J, Han F, He X, Hu CS, Hu DS, Hu GY, Jiang H, Jiang W, Jin F, Lang JY, Li JG, Lin SJ, Liu X, Liu QF, Ma L, Mai HQ, Qin JY, Shen LF, Sun Y, Wang PG, Wang RS, Wang RZ, Wang XS, Wang Y, Wu H, Xia YF, Xiao SW, Yang KY, Yi JL, Zhu XD, Ma J.
Cancer Commun (Lond). 2021 Nov;41(11):1195-1227. doi: 10.1002/cac2.12218. Epub 2021 Oct 26.
PMID:34699681
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up().
Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, Halámková J, Mattheis S, Baujat B, Hardillo J, Smeele L, van Herpen C, Castro A, Machiels JP; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org; EURACAN.
Ann Oncol. 2021 Apr;32(4):452-465. doi: 10.1016/j.annonc.2020.12.007. Epub 2020 Dec 25.
PMID:33358989
Malignant peripheral nerve sheath tumor of the nasal cavity and nasopharynx in a child: A case report.
Li Q, Pan H, Li L, Cao J.
Medicine (Baltimore). 2019 Jan;98(4):e14223. doi: 10.1097/MD.0000000000014223.
PMID:30681599
PET/CT: Nasopharyngeal Cancers.
Xie C, Vardhanabhuti V.
PET Clin. 2022 Apr;17(2):285-296. doi: 10.1016/j.cpet.2021.12.006. Epub 2022 Mar 4.
PMID:35256301
Characterization of the nasopharynx microbiota in patients with nasopharyngeal carcinoma vs. healthy controls.